CN102988498A - Medicine composition for treating leucoderma - Google Patents
Medicine composition for treating leucoderma Download PDFInfo
- Publication number
- CN102988498A CN102988498A CN201210404986XA CN201210404986A CN102988498A CN 102988498 A CN102988498 A CN 102988498A CN 201210404986X A CN201210404986X A CN 201210404986XA CN 201210404986 A CN201210404986 A CN 201210404986A CN 102988498 A CN102988498 A CN 102988498A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine composition
- vitiligo
- semen sesami
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to an oral Chinese medicine preparation in the field of medicines, and in particular relates to a medicine composition for treating leucoderma. The medicine composition is prepared from the following raw materials in parts by weight: 10-30 parts of Chinese angelica, 10-20 parts of codonopsis pilosula, 10-20 parts of safflower, 10-15 parts of leech, 10-15 parts of fig, 10-15 parts of black sesame semen sesami nigrum, 10-15 parts of polygonum multiflorum and 5-10 parts of musk. The medicine composition is good in stability without recurring.
Description
Technical field
The invention belongs to the oral medicinal herb preparation of field of medicaments, be specifically related to a kind of leukodermic pharmaceutical composition for the treatment of.
Background technology
Vitiligo is a kind of common multiple pigmented dermatosis.This disease forms white macula as feature take local or general property depigmentation, is a kind of acquired limitation or general property depigmentation of skin, is the common skin diseases of an impact beauty treatment, easily diagnosis, and treatment is difficult.Traditional Chinese medical science medical science is referred to as " vitiligo " or " vitiligo ".Vitiligo is that posteriority is lost the limitation white patch that occurs because skin pigment takes off, so that local skin is the white macula sample.Medically usually this pathological changes depigmentation.
This disease all has generation all over the world, and India's sickness rate is the highest, and China has ten million people morbidity approximately, can involve all races, and the men and women falls ill without marked difference.Vitiligo is divided into congenital vitiligo: congenital vitiligo is a kind of constitutional, limitation or general property depigmentation of skin, is that hypofunction, the forfeiture of tryrosinase system in the melanocyte owing to skin and hair follicle causes.Skin lesion for have not a particle of pigment, differ in size, different, white macula all can occur everywhere in whole body, clear border, the border pigment is darker, hair follicle bleaches in the speckle.
Traumatic vitiligo: traumatic vitiligo is one acquired, general property depigmentation of skin, is a kind of common skin diseases that affects beauty treatment.Easily diagnose and the treatment difficulty.Motherland's medical science is referred to as " leucoderma " or " vitiligo ".By wound, the vitiligo of bringing out such as perform the operation, scratch is called traumatic vitiligo.
The segmental vitiligo: the segmental vitiligo is a kind of incontinentia pigmentosa achromians dermatoses of limitation.The teenager morbidity is more.Skin lesion is clearly white macula of boundary, circle, oval or not shaping.Can betide any position of health.No conscious sympton does not affect healthyly, but impact beauty treatment can bring spiritual misery to patient.Minority small pieces skin lesion can disappear voluntarily, and Nervous and Mental Factors, Exposure to Sunlight, wound can make sx↑ or bring out primary disease.Etiology unknown has theory of autoimmunity, neuro humor theory, melanocyte autoclasia theory etc.The extensive person of disease damage can try out photochemotherapy, and namely oral psoralen adds the long wave ultraviolet radiation.Local available various corticosteroid hormone preparations
Although vitiligo is a kind of dermatosis, no matter be western medicine, or Chinese medicine, think that all leukodermic pathogeny is in the body, the treatment to appearance of pure is difficult to reach the purpose of healing.
Summary of the invention
The technical problem to be solved in the present invention provides a kind of leukodermic pharmaceutical composition for the treatment of of good stability.
Content of the present invention is, made by the material component of following parts by weight,
Radix Angelicae Sinensis 10-30 part, Radix Codonopsis 10-20 part, Flos Carthami 10-20 part, Hirudo 10-15 part, Fructus Fici 10-15 part, Semen Sesami Nigrum 10-15 part, Radix Polygoni Multiflori 10-15 part, Moschus 5-10 part.
Preferably, made by the raw material of following parts by weight,
Radix Angelicae Sinensis 20-30 part, Radix Codonopsis 15-20 part, Flos Carthami 15-20 part, Hirudo 13-15 part, Fructus Fici 13-15 part, Semen Sesami Nigrum 13-15 part, Radix Polygoni Multiflori 13-15 part, Moschus 5-8 part.
Most preferred, it is characterized in that, made by the raw material of following parts by weight,
30 parts of Radix Angelicae Sinensis, 20 parts of Radix Codonopsis, 20 parts on Flos Carthami, 13 parts of Hirudos, 13 parts of Fructus Ficis, 13 parts of Semen Sesami Nigrums, 13 parts of Radix Polygoni Multiflori, 5 parts in Moschus.
Preparation method of the present invention is that above-mentioned component is mixed, and then crushing screening makes corresponding dosage form according to the dosage form preparation method of separately Chinese medicine.
Instructions of taking of the present invention is, and is oral, every day 2-3 time, and a 5-10g, the morning, noon and afternoon rush after meal warm water and take.
The invention has the beneficial effects as follows that the function that each component of the present invention has separately is: Radix Angelicae Sinensis: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation; Radix Codonopsis, invigorating the spleen and replenishing QI and taste, relieving thirst and restlessness.A little less than the middle feeble QI, mend in order to transfer, very smooth and proper; Flos Carthami is invigorated blood circulation, moisturizes, and pain relieving, loose swollen, stimulate the menstrual flow; Hirudo: removing blood stasis, by becoming silted up; Fructus Fici, invigorating the stomach and promoting bowel movement, subduing swelling and detoxicating; Semen Sesami Nigrum: invigorating the liver and kidney, benefiting essence-blood, intestine moistening is dry.Be used for dizziness and blurred vision, Hiccough and deaf, early whitening of beard and hair, post disease alopecia, dryness of the intestine constipation; Radix Polygoni Multiflori: enter the Gallbladder Channel of Foot-Shaoyang, triple energizer meridian, heart channel of Hand-Shaoyin, kidney meridian; Moschus: the refreshment of having one's ideas straightened out, promoting blood circulation to restore menstrual flow, pain relieving is hastened parturition.
The specific embodiment
Embodiment 1
The present invention is made than component by following weight fraction, 30 parts of Radix Angelicae Sinensis, 20 parts of Radix Codonopsis, 20 parts on Flos Carthami, 13 parts of Hirudos, 13 parts of Fructus Ficis, 13 parts of Semen Sesami Nigrums, 13 parts of Radix Polygoni Multiflori, 5 parts in Moschus.
Preparation method of the present invention is above-mentioned component to be mixed crushing screening.
Embodiment 2
The present invention is made by the material component of following parts by weight,
30 parts of Radix Angelicae Sinensis, 20 parts of Radix Codonopsis, 20 parts on Flos Carthami, 10 parts of Hirudos, 10 parts of Fructus Ficis, 15 parts of Semen Sesami Nigrums, 10 parts of Radix Polygoni Multiflori, 5 parts in Moschus.
Preparation method of the present invention is above-mentioned component to be mixed crushing screening.
Embodiment 3
The present invention is made by the material component of following parts by weight,
10 parts of Radix Angelicae Sinensis, 10 parts of Radix Codonopsis, 10 parts on Flos Carthami, 15 parts of Hirudos, 15 parts of Fructus Ficis, 10 parts of Semen Sesami Nigrums, 15 parts of Radix Polygoni Multiflori, 10 parts in Moschus.
Preparation method of the present invention is above-mentioned component to be mixed crushing screening.
Medicine of the present invention prepares vitiligo 201 examples, and effective percentage reaches 98.5%.
Pharmaceutical composition with embodiment 1 preparation is taken, and below is several model cases.
Liu, the woman, 33 years old, people from Wuhan, Hubei suffered from vitiligo 3 places, back, about 30cm
2, ill 4 years, behind the pharmaceutical composition of use embodiment 1 preparation, recovery from illness after 6 months, nothing recurrence after the recovery from illness.
Lee.The man, 45 years old, people from Gongan County, Hubei, the large tracts of land such as arm, lower limb are ill, ill 10 years, permanent treatment, poor effect, take the pharmaceutical composition of embodiment 1 preparation after, recovery from illness after 9 months, after the recovery from illness without recurrence.
Claims (3)
1. the leukodermic pharmaceutical composition for the treatment of is characterized in that, made by the material component of following parts by weight,
Radix Angelicae Sinensis 10-30 part, Radix Codonopsis 10-20 part, Flos Carthami 10-20 part, Hirudo 10-15 part, Fructus Fici 10-15 part, Semen Sesami Nigrum 10-15 part, Radix Polygoni Multiflori 10-15 part, Moschus 5-10 part.
2. the leukodermic pharmaceutical composition for the treatment of according to claim 1 is characterized in that, made by the raw material of following parts by weight,
Radix Angelicae Sinensis 20-30 part, Radix Codonopsis 15-20 part, Flos Carthami 15-20 part, Hirudo 13-15 part, Fructus Fici 13-15 part, Semen Sesami Nigrum 13-15 part, Radix Polygoni Multiflori 13-15 part, Moschus 5-8 part.
3. the leukodermic pharmaceutical composition for the treatment of according to claim 1 and 2 is characterized in that, made by the raw material of following parts by weight,
30 parts of Radix Angelicae Sinensis, 20 parts of Radix Codonopsis, 20 parts on Flos Carthami, 13 parts of Hirudos, 13 parts of Fructus Ficis, 13 parts of Semen Sesami Nigrums, 13 parts of Radix Polygoni Multiflori, 5 parts in Moschus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210404986.XA CN102988498B (en) | 2012-10-13 | 2012-10-13 | Medicine composition for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210404986.XA CN102988498B (en) | 2012-10-13 | 2012-10-13 | Medicine composition for treating leucoderma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102988498A true CN102988498A (en) | 2013-03-27 |
| CN102988498B CN102988498B (en) | 2014-11-26 |
Family
ID=47917924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210404986.XA Expired - Fee Related CN102988498B (en) | 2012-10-13 | 2012-10-13 | Medicine composition for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102988498B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006431A (en) * | 2022-08-09 | 2022-09-06 | 云南三江本草药业有限公司 | Application of poecilobdella manillensis in preparing medicine for treating leucoderma and medicinal preparation |
| WO2024161189A1 (en) * | 2023-01-31 | 2024-08-08 | Ortiz Soto Carlos Humberto | Natural formulation based on extracts of ingredients belonging to the family caricaceae and others, for skin pigmentation |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1175436A (en) * | 1997-06-20 | 1998-03-11 | 苏新发 | Chinese patent drug for treatment of leukoderma |
| CN1177489A (en) * | 1997-09-02 | 1998-04-01 | 史培明 | Chines medicine for treating vitiligo and preparation method thereof |
| US20010044422A1 (en) * | 1999-12-29 | 2001-11-22 | Huiping Zhao | Composition and method for the treatment of vitiligo |
| US20030072813A1 (en) * | 1999-12-29 | 2003-04-17 | Huiping Zhao | Composition and method for the treatment of vitiligo |
| CN101461847A (en) * | 2009-01-13 | 2009-06-24 | 牛付立 | Medicament composition for treating leukoderma |
| KR20100029341A (en) * | 2008-09-08 | 2010-03-17 | (주)한중보건연구원 | Skin (white spot) rejuvenation ointment |
| CN102441067A (en) * | 2010-09-30 | 2012-05-09 | 张赞 | Preparation method of medicine for treating leucoderma |
-
2012
- 2012-10-13 CN CN201210404986.XA patent/CN102988498B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1175436A (en) * | 1997-06-20 | 1998-03-11 | 苏新发 | Chinese patent drug for treatment of leukoderma |
| CN1177489A (en) * | 1997-09-02 | 1998-04-01 | 史培明 | Chines medicine for treating vitiligo and preparation method thereof |
| US20010044422A1 (en) * | 1999-12-29 | 2001-11-22 | Huiping Zhao | Composition and method for the treatment of vitiligo |
| US20030072813A1 (en) * | 1999-12-29 | 2003-04-17 | Huiping Zhao | Composition and method for the treatment of vitiligo |
| KR20100029341A (en) * | 2008-09-08 | 2010-03-17 | (주)한중보건연구원 | Skin (white spot) rejuvenation ointment |
| CN101461847A (en) * | 2009-01-13 | 2009-06-24 | 牛付立 | Medicament composition for treating leukoderma |
| CN102441067A (en) * | 2010-09-30 | 2012-05-09 | 张赞 | Preparation method of medicine for treating leucoderma |
Non-Patent Citations (1)
| Title |
|---|
| 宋业强等: "9个中药复方水提取物对蘑菇酪氨酸酶活性的影响", 《中医临床研究》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006431A (en) * | 2022-08-09 | 2022-09-06 | 云南三江本草药业有限公司 | Application of poecilobdella manillensis in preparing medicine for treating leucoderma and medicinal preparation |
| WO2024161189A1 (en) * | 2023-01-31 | 2024-08-08 | Ortiz Soto Carlos Humberto | Natural formulation based on extracts of ingredients belonging to the family caricaceae and others, for skin pigmentation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102988498B (en) | 2014-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101513460B (en) | Traditional Chinese medicine for curing alopecia | |
| CN101804185B (en) | Chinese medicinal compound extract for whitening and removing freckles and preparation method thereof | |
| CN103169881B (en) | Chinese medicament health product for supplementing female hormone for women during menopause and preparation method thereof | |
| CN102293874B (en) | Multifunctional medicinal pillow and preparation method thereof | |
| CN101284073B (en) | Combination medicine for curing the hoary hair | |
| CN1318044C (en) | Chinese herbal medicine prepn for strengthening kidney-Yang | |
| CN102988498B (en) | Medicine composition for treating leucoderma | |
| CN104740583A (en) | Traditional Chinese medicine preparation for relieving Crohn's disease and preparation method for traditional Chinese medicine preparation | |
| CN105770669A (en) | Medicinal preparation for treating colour spots and application thereof | |
| CN101224271A (en) | Chinese traditional medicine compounds for treating poliosis | |
| CN104398990A (en) | Chinese medicinal composition for treating insomnia and palpitation and preparation method thereof | |
| CN103223048B (en) | Traditional Chinese medicine composition for treating facial leukoderma | |
| CN101176758B (en) | Medicine for treating leucoderma and its preparation method | |
| CN105816532A (en) | Hair care cream and preparation method thereof | |
| CN105641352A (en) | Medicinal preparation for treating facial stain and application thereof | |
| CN104524479A (en) | Traditional Chinese medicine composition for treating premenstrual syndrome and preparation method of traditional Chinese medicine composition | |
| CN104971204A (en) | Kidney-tonifying and resuscitation-inducing pill and medicinal strip cooperating with acupuncture for treating neurological tinnitus | |
| CN105796749B (en) | A kind of traditional Chinese medicine composition for relieving asthenopia | |
| CN103948684A (en) | Externally-applied liniment for treating leucoderma | |
| CN104096018A (en) | Traditional Chinese medicine composition for treating facial neural paralysis | |
| CN104435582A (en) | Traditional Chinese medicine plaster for treating depression and insomnia of middle-aged and old people | |
| CN103520673A (en) | Traditional Chinese medicine for treating deficiency of Qi and blood syndrome type of menopathy | |
| CN108815332A (en) | A kind of composition of tonifying kidney and strengthening yang and the preparation method and application thereof | |
| CN105617139A (en) | Traditional Chinese medicine composition with skin-whitening effect as well as preparation method therefor and application thereof | |
| CN104491278A (en) | Traditional Chinese medicinal composition for treating leucoderma due to qi stagnation and blood stasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: GUANGDONG HUABO ENTERPRISE MANAGEMENT CONSULTING C Free format text: FORMER OWNER: CIXI RUIMA ELECTRONIC CO., LTD. Effective date: 20150709 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150709 Address after: 510640 Guangdong city of Guangzhou province Tianhe District gold Yinglu No. 1 was 1106 room two Patentee after: Guangdong Huabo Enterprise Management Consulting Co., Ltd. Address before: 315316 Zhejiang city of Cixi province Guanhaiwei town Industrial Park West Patentee before: Cixi Ruima Electronic Co., Ltd. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160218 Address after: Tianhe District Tong East Road Guangzhou city Guangdong province 510665 B-101 No. 5, room B-118 Patentee after: Guangdong Gaohang Intellectual Property Operation Co., Ltd. Address before: 510640 Guangdong city of Guangzhou province Tianhe District gold Yinglu No. 1 was 1106 room two Patentee before: Guangdong Huabo Enterprise Management Consulting Co., Ltd. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20161125 Address after: 532800 the Guangxi Zhuang Autonomous Region Chongzuo City Road Tianbao Tiandeng County town 108 days Patentee after: Nong Dezhi Address before: Tianhe District Tong East Road Guangzhou city Guangdong province 510665 B-101 No. 5, room B-118 Patentee before: Guangdong Gaohang Intellectual Property Operation Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141126 Termination date: 20171013 |